384 related articles for article (PubMed ID: 10589589)
1. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
Kern KA
J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
[TBL] [Abstract][Full Text] [Related]
2. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
3. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer.
D'Eredita' G; Ferrarese F; Cecere V; Massa ST; de Carne F; Fabiano G
Ann Surg Oncol; 2003 Oct; 10(8):942-7. PubMed ID: 14527915
[TBL] [Abstract][Full Text] [Related]
4. Improved lymphatic mapping technique for breast cancer.
Beitsch PD; Clifford E; Whitworth P; Abarca A
Breast J; 2001; 7(4):219-23. PubMed ID: 11678798
[TBL] [Abstract][Full Text] [Related]
5. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
6. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of lymphatic mapping with sub-areolar injection of patent blue dye, in the typification of breast cancer].
Gallegos-Hernández JF; Chávez-García M
Rev Invest Clin; 2003; 55(4):407-11. PubMed ID: 14635604
[TBL] [Abstract][Full Text] [Related]
9. A further validation of subareolar injection technique for breast sentinel lymph node biopsy.
D'Eredita G; Giardina C; Guerrieri AM; Berardi T
Ann Surg Oncol; 2006 May; 13(5):701-7. PubMed ID: 16523366
[TBL] [Abstract][Full Text] [Related]
10. [Sentinel lymphatic node biopsy for breast cancer in practice].
Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
[TBL] [Abstract][Full Text] [Related]
11. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
13. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node imaging and biopsy in breast cancer patients.
Donahue EJ
Am J Surg; 2001 Oct; 182(4):426-8. PubMed ID: 11720685
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
[TBL] [Abstract][Full Text] [Related]
16. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
[TBL] [Abstract][Full Text] [Related]
17. [lymphatic Mapping and Sentinel Lymph Node Biopsy in patients with Breast Cancer ].
Gallegos-Hernández JF; Chávez-García MA; Nájera I; Ramírez-Ramírez L; Durán-Martínez M
Gac Med Mex; 2003; 139(3):205-8. PubMed ID: 12872412
[TBL] [Abstract][Full Text] [Related]
18. [Subareolar injection for sentinel lymph node biopsy in multiple breast cancer].
D'Eredità G; Troilo VL; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
G Chir; 2006; 27(11-12):436-41. PubMed ID: 17198554
[TBL] [Abstract][Full Text] [Related]
19. Combination of subareolar blue dye and peritumoral RI for sentinel lymph node biopsy.
Tsunoda N; Iwata H; Sarumaru S; Mizutani M; Iwase T; Miura S
Breast Cancer; 2002; 9(4):323-8. PubMed ID: 12459714
[TBL] [Abstract][Full Text] [Related]
20. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
